Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × niraparib × Thoracic × Clear all

Phase

Status

Sponsor Class

OTHER 7 INDUSTRY 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Head & Neck 1 Breast 1

Conditions

SCLC,Extensive Stage 1

Interventions

Cisplatin 36 Carboplatin 35 Radiotherapy 28 Paclitaxel 28 Pemetrexed 15 Gemcitabine 15 Etoposide 15 Docetaxel 15 Bevacizumab 10 Radiosurgery 9 Magnetic Resonance Spectroscopy 8 durvalumab 7 Taxes 6 Cetuximab 6 pembrolizumab 5 Specimen Handling 5 Ramucirumab 5 Irinotecan 5 Gene Expression Profiling 5 Filgrastim 5 Erlotinib Hydrochloride 5 Vinorelbine 4 Polymerase Chain Reaction 4 Neoadjuvant Therapy 4 Chemotherapy, Adjuvant 4 tremelimumab 3 osimertinib 3 cediranib 3 Watchful Waiting 3 Radiotherapy, Conformal 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05718323 2026-02-06

RAISE

ETOP IBCSG Partners Foundation

Phase 2 Recruiting

SCLC,Extensive Stage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡